|
| Press Releases |
|
 |
|
| Tuesday, January 2, 2024 |
|
|
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA |
| more info >> |
|
| Wednesday, December 13, 2023 |
|
|
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL |
| more info >> |
|
| Monday, August 5, 2024 |
|
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 16, 2024 |
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating |
| In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development. more info >> |
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating |
| In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development. more info >> |
|
| Tuesday, June 25, 2024 |
|
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
| On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
| On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
| more info >> |
|
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
| more info >> |
|
| Tuesday, April 23, 2024 |
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Nanshan Aluminium International擬來港IPO
Oct 7, 2024 22:01 HKT/SGT
|
|
|
Nanshan Aluminium International拟来港IPO
Oct 7, 2024 21:35 HKT/SGT
|
|
|
Military Metals Enters into LOI to Acquire Two Antimony and One Tin Property in the European Union
Oct 7, 2024 20:39 HKT/SGT
|
|
|
32nd Edition of Digital Transformation Summit Announced by Exito Media Concepts
Oct 7, 2024 15:45 HKT/SGT
|
|
|
Unlocking India's Offshoring Advantage: Your Ultimate Guide for 2024
Oct 7, 2024 13:00 HKT/SGT
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 7, 2024 10:40 HKT/SGT
|
|
|
JCB to offer Google Pay(TM) in Japan
Oct 7, 2024 11:00 JST
|
|
|
Success at the 9th Annual REITs and Real Estate Investment Summit Asia Pacific 2024(TM): Driving Profits Through Sustainable Technology and Net Zero Imperatives
Oct 7, 2024 09:00 HKT/SGT
|
|
|
BluWave-ai、特許件数を順調に拡大―米国特許商標庁に30件の特許を出願し、うち7件はすでに付与済み
Oct 7, 2024 08:00: JST
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 20:00: JST
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 19:00 HKT/SGT
|
|
|
CNNが人々の生活をつなぐ医療の未来を探る特別番組「Tomorrow Transformed」を放送
Oct 4, 2024 19:00: JST
|
|
|
Hong Kong Films @ Busan 2024 opens tomorrow
Oct 4, 2024 17:18 HKT/SGT
|
|
|
三菱重工、防衛省向け3,000トン型潜水艦「ちょうげい」の命名式・進水式を神戸造船所で実施
Oct 4, 2024 15:00: JST
|
|
|
Honda、「N-BOX」が2024年度上半期 新車販売台数 第1位を獲得
Oct 4, 2024 15:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
